Related Experiment Videos
Recent translational research: microarray expression profiling of breast cancer--beyond classification and prognostic
1Department of Hematology/Oncology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, USA. cawilson@ucla.edu
Breast Cancer Research : BCR
|August 21, 2004
Summary
Genomic expression profiling helps classify breast cancer subtypes. Further research aims to use this technology to identify key signaling pathways driving tumor growth in each subtype.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Genomic expression profiling has advanced human breast cancer subclassification.
- Understanding molecular characteristics and clinical behavior is crucial for treatment.
Purpose of the Study:
- To investigate the utility of genomic expression profiling in identifying dominant signaling pathways in breast cancer subtypes.
- To explore the integration of model system data with primary tumor expression profiles.
Main Methods:
- Utilizing genomic expression profiling data.
- Analyzing data from experimental manipulation of model systems.
- Integrating diverse datasets from primary tumors.
Main Results:
- Expression profiling aids in breast cancer subclassification.
- Identifying dominant signaling pathways remains a challenge.
- Integrating model system and primary tumor data presents obstacles.
Conclusions:
- Genomic expression profiling is valuable for breast cancer subclassification.
- Further research is needed to effectively identify pathway signatures driving tumor progression.
- Overcoming data integration challenges is key for future advancements.